![]() |
市場調查報告書
商品編碼
1447098
Caralluma 萃取物市場預測至 2030 年:按形式、成分、分銷管道、應用、最終用戶和地區進行的全球分析Caralluma Extract Market Forecasts to 2030 - Global Analysis By Form, Ingredient, Distribution Channel, Application, End User and By Geography |
根據 Stratistics MRC 的數據,全球卡拉盧馬萃取物市場在預測期內將以 5.1% 的年複合成長率成長。
Caralluma 萃取物是從原產於印度的 Caralluma fimbriata 植物中提取的。它傳統上在印度文化中因其抑制食慾的特性而被使用。人們認為這種萃取物透過影響大腦中調節食慾的特定神經傳導物質而發揮作用。 Caralluma 萃取物富含抗氧化劑,具有促進心血管健康和調節血糖值等健康益處。
根據 William Reed Business Media Ltd. 2016 年發布的資料,大約 79% 的歐洲人願意為有機補充品等產品金額更多費用,因為我希望他們對改善整體健康更感興趣。
對天然和植物來源成分的需求不斷增加
消費者擴大尋求合成補充品的替代品,並青睞卡拉魯瑪等萃取物,因為它們被認為對健康有益且安全。這一趨勢是由健康意識的增強以及對符合永續和環保生活方式的產品的渴望所推動的。因此,卡拉盧馬萃取物作為體重管理和食慾抑制的天然解決方案越來越受歡迎,推動市場成長並增加其在營養補充食品的影響力。
對有效性的擔憂
圍繞萃取物萃取物的功效問題主要圍繞著個體反應和有限的長期研究。儘管科學研究表明它可能對體重管理和抑制食慾有效,但使用者之間的結果不一致,並且尚未進行大型臨床試驗,因此消費者普遍持懷疑態度。如果沒有確切的證據證明對所有人都有效,消費者可能會選擇替代產品,從而抑制市場成長。
擴大營養補充食品
由於人口變化和健康意識食品等因素,營養補充產業經歷了強勁成長,Caralluma 萃取物正在成為一種受歡迎的產品。這一市場擴張為 Caralluma 萃取物提供了滿足更廣泛消費者群體的機會,鼓勵創新和產品多樣化。因此,蓬勃發展的營養補充市場起到了催化劑的作用,使 Caralluma 萃取物在天然保健補充品的競爭格局中處於有利地位。
來自合成替代品的競爭
由於合成減重藥和食慾抑制劑具有見效更快和市場地位穩固等優勢,一些消費者對於選擇天然替代品(如卡拉盧馬萃取物)則猶豫不決。此外,合成替代品的積極行銷和製藥公司的支持可能會掩蓋卡拉盧馬萃取物的好處並限制市場滲透。這種競爭已成為Caralluma萃取物的進入壁壘,阻礙了市場的擴展和普及。
COVID-19 的影響
COVID-19 大流行造成供應鏈中斷,導致供應和價格波動,從而影響了卡拉盧馬萃取物市場。由於當地的封鎖措施和消費者的購買行為,消費者對含有卡拉盧馬萃取物的保健補充食品的需求既激增又下降。然而,大流行期間人們對健康和保健意識的增強也推動了市場的成長,因為消費者尋求自然療法來支持他們的免疫系統和整體健康。
預計粉末細分市場在預測期內將是最大的
預計粉末市場將出現良好的成長。 Caralluma 萃取物粉末因其在體重管理和抑制食慾方面的潛在益處而受到健康和保健行業的青睞。這種粉末型態可以輕鬆融入各種產品中,如飲料、冰沙和營養補充,提供多種消費方式。其方便的形式和可感知的有效性使其成為營養補充食品的熱門選擇,推動了全球需求的成長。
預計營養補充食品在預測期內年複合成長率最高
由於其潛在的食慾抑制特性,營養補充食品預計在預測期內將出現最高的年複合成長率。 Caralluma 萃取物是體重管理產品中的流行成分。 Caralluma 萃取物被認為是透過影響下丘腦發揮作用,從而調節飢餓水平。此外,它可能會抑制某些參與脂肪生成的酵素的活性。將其納入營養補充食品了其在支持健康體重管理目標和促進整體健康方面的作用。
由於消費者偏好的增加和收入水準的提高,預計北美在預測期內將呈現最高的年複合成長率。該地區食品營養補充,加上肥胖率的上升,增加了對卡拉盧馬萃取物的需求。此外,強調天然來源和健康益處的策略行銷工作繼續推動北美卡拉盧馬萃取物市場的擴張。
由於健康意識的提高和肥胖相關問題的盛行率上升,預計亞太地區在預測期內將佔據最大的市場佔有率。像印度這樣的國家,Caralluma fimbriata 的原產地,由於其傳統用途和文化接受度,需求量龐大。此外,中國和日本等國家的食品營養補充正在快速成長,進一步推動了卡拉盧瑪萃取物的採用。由於城市人口的增加和向自然療法的轉變,預計亞太地區卡拉盧馬萃取物市場將持續擴大。
According to Stratistics MRC, the Global Caralluma Extract Market is growing at a CAGR of 5.1% during the forecast period. Caralluma extract is derived from the Caralluma fimbriata plant, native to India. It has been traditionally used in Indian culture for its appetite-suppressing properties. This extract is believed to work by affecting certain neurotransmitters in the brain that regulate appetite. Caralluma extract is rich in antioxidants and also offers health benefits such as improved cardiovascular health and blood sugar regulation.
According to data published by William Reed Business Media Ltd. in 2016, approximately 79% of Europeans are willing to pay more for products, such as organic supplements, owing to greater interest in improving overall wellbeing.
Growing demand for natural and plant-based ingredients
Consumers are increasingly seeking alternatives to synthetic supplements, favouring botanical extracts like caralluma for their perceived health benefits and safety. This trend is fuelled by growing health consciousness and a desire for products that align with sustainable and environmentally friendly lifestyles. As a result, caralluma extract is experiencing rising popularity as a natural solution for weight management and appetite control, driving market growth and expanding its presence in the dietary supplements industry.
Efficacy concerns
Efficacy concerns surrounding Caralluma Extract primarily revolve around varying individual responses and limited long-term studies. While scientific research suggests its potential benefits for weight management and appetite suppression, inconsistent results among users and a lack of extensive clinical trials raise skepticism among consumers. Without conclusive evidence demonstrating its effectiveness for all individuals, consumers may opt for alternative products, inhibiting the growth of the market.
Expanding dietary supplements market
With the dietary supplements sector experiencing robust growth, fuelled by factors like shifting demographics and health-conscious lifestyles, caralluma extract emerges as a sought-after product. This market expansion fosters opportunities for caralluma extract to cater to a broader consumer base, prompting innovation and product diversification. Thus, the flourishing dietary supplements market acts as a catalyst, positioning caralluma extract favourably within the competitive landscape of natural health supplements.
Competition from synthetic alternatives
Synthetic weight loss medications and appetite suppressants offer perceived advantages, such as faster results and established market presence, deterring some consumers from opting for natural alternatives like caralluma extract. Additionally, aggressive marketing and pharmaceutical backing of synthetic alternatives can overshadow the benefits of caralluma extract, limiting its market penetration. This competition creates barriers to entry for caralluma extract, hindering its market expansion and adoption.
Covid-19 Impact
The covid-19 pandemic has impacted the caralluma extract market by causing disruptions in the supply chain, leading to fluctuations in availability and pricing. Consumer demand for health supplements, including caralluma extract, has seen both spikes and declines depending on regional lockdown measures and consumer purchasing behaviour. However, increased awareness of health and wellness during the pandemic has also driven some growth in the market as consumers seek natural remedies to support their immune systems and overall well-being.
The powder segment is expected to be the largest during the forecast period
The powder segment is estimated to have a lucrative growth. Caralluma extract powder is gaining traction in the health and wellness industry for its potential benefits in weight management and appetite suppression. This powdered form offers versatility in consumption, allowing easy incorporation into various products such as beverages, smoothies, and dietary supplements. Its convenient form factor and perceived effectiveness make it a popular choice in the dietary supplements market, driving its growing demands globally.
The dietary supplements segment is expected to have the highest CAGR during the forecast period
The dietary supplements segment is anticipated to witness the highest CAGR growth during the forecast period, due to its potential appetite-suppressing properties. It is a popular ingredient in weight management products. Caralluma extract is believed to work by affecting the hypothalamus, which regulates hunger levels. Additionally, it may inhibit the activity of certain enzymes involved in fat production. Its inclusion in dietary supplements underscores its role in supporting healthy weight management goals, promoting overall wellness.
North America is projected to have the highest CAGR over the forecast period, owing to the increasing consumer preferences and rising income levels. The region's robust dietary supplements market, coupled with rising obesity rates, contributes to the demand for caralluma extract. Further, strategic marketing efforts emphasizing its natural origins and health benefits continue to fuel the expansion of the Caralluma Extract market in North America.
Asia Pacific is projected to hold the largest market share during the forecast period owing to increasing health consciousness and the rising prevalence of obesity-related issues. Countries like India, where caralluma fimbriata is native, witness significant demand due to its traditional use and cultural acceptance. Moreover, the burgeoning dietary supplements market in countries like China and Japan further propels the adoption of caralluma extract. With expanding urban populations and a shift towards natural remedies, the Asia-Pacific caralluma extract market is poised for continued expansion.
Key players in the market
Some of the key players profiled in the Caralluma Extract Market include Bio Nutrition Inc., Creative Bioscience, Gencor Pacific Group, Nutra Rise, BioGenetic Laboratories, Pure Encapsulations, Source Naturals, Swanson Health Products, NOW Foods, Solaray, Sabinsa Corporation, Natreon Inc., NutraMarks Inc. and Novel Nutrients Private Limited.
In February 2021, Gencor launched Caralluma fimbriata extract for stress and anxiety. The ingredient has been studied in animals and humans, including a double-blind, randomized clinical trial with 97 adults self-reporting mild to moderate anxiety.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.